186 related articles for article (PubMed ID: 27556695)
1. PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.
Zheng Y; Zhao G; Xu B; Liu C; Li C; Zhang X; Chang X
Oncotarget; 2016 Sep; 7(38):62159-62176. PubMed ID: 27556695
[TBL] [Abstract][Full Text] [Related]
2. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.
Cui YY; Yan L; Zhou J; Zhao S; Zheng YB; Sun BH; Lv HT; Rong FN; Chang XT
Tumour Biol; 2016 Apr; 37(4):5375-83. PubMed ID: 26563365
[TBL] [Abstract][Full Text] [Related]
3. PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up-regulates CA9 expression.
Liu C; Tang J; Li C; Pu G; Yang D; Chang X
Mol Carcinog; 2019 Jan; 58(1):66-75. PubMed ID: 30242913
[TBL] [Abstract][Full Text] [Related]
4. Investigating the pathogenic role of PADI4 in oesophageal cancer.
Chang X; Hou X; Pan J; Fang K; Wang L; Han J
Int J Biol Sci; 2011; 7(6):769-81. PubMed ID: 21698003
[TBL] [Abstract][Full Text] [Related]
5. PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8.
Chang XT; Wu H; Li HL; Li HL; Zheng YB
BMC Gastroenterol; 2022 Jan; 22(1):25. PubMed ID: 35045833
[TBL] [Abstract][Full Text] [Related]
6. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.
Wang Y; Song X; Song Y; Fang K; Chang X
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17253-17268. PubMed ID: 37804426
[TBL] [Abstract][Full Text] [Related]
7. Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.
Guo W; Zheng Y; Xu B; Ma F; Li C; Zhang X; Wang Y; Chang X
Onco Targets Ther; 2017; 10():1475-1485. PubMed ID: 28331341
[TBL] [Abstract][Full Text] [Related]
8. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
9. Increased PADI4 expression in blood and tissues of patients with malignant tumors.
Chang X; Han J; Pang L; Zhao Y; Yang Y; Shen Z
BMC Cancer; 2009 Jan; 9():40. PubMed ID: 19183436
[TBL] [Abstract][Full Text] [Related]
10. Expression of PADI4 in patients with ankylosing spondylitis and its role in mediating the effects of TNF-α on the proliferation and osteogenic differentiation of human mesenchymal stem cells.
Yang Y; Dai M
Int J Mol Med; 2015 Aug; 36(2):565-70. PubMed ID: 26082376
[TBL] [Abstract][Full Text] [Related]
11. Claudin 1 mediates tumor necrosis factor alpha-induced cell migration in human gastric cancer cells.
Shiozaki A; Shimizu H; Ichikawa D; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Nako Y; Liu M; Otsuji E
World J Gastroenterol; 2014 Dec; 20(47):17863-76. PubMed ID: 25548484
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and biophysical characterization of PADI4 supports its involvement in cancer.
Neira JL; Araujo-Abad S; Cámara-Artigas A; Rizzuti B; Abian O; Giudici AM; Velazquez-Campoy A; de Juan Romero C
Arch Biochem Biophys; 2022 Mar; 717():109125. PubMed ID: 35081374
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways.
Sun J; Jiang J; Lu K; Chen Q; Tao D; Chen Z
Mol Cell Biochem; 2017 Feb; 426(1-2):17-26. PubMed ID: 27878499
[TBL] [Abstract][Full Text] [Related]
14. Investigating a pathogenic role for TXNDC5 in tumors.
Chang X; Xu B; Wang L; Wang Y; Wang Y; Yan S
Int J Oncol; 2013 Dec; 43(6):1871-84. PubMed ID: 24100949
[TBL] [Abstract][Full Text] [Related]
15. Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization.
Wang Y; Lyu Y; Tu K; Xu Q; Yang Y; Salman S; Le N; Lu H; Chen C; Zhu Y; Wang R; Liu Q; Semenza GL
Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34452909
[TBL] [Abstract][Full Text] [Related]
16. PADI4 Polymorphisms in Iranian Patients with Rheumatoid Arthritis.
Shamsian E; Azarian M; Akhlaghi M; Samaei M; Jamshidi AR; Assar S; Shakiba Y; Gharibdoost F; Nourijelyani K; Mahmoudi M
Acta Reumatol Port; 2016; 41(4):338-343. PubMed ID: 27182695
[TBL] [Abstract][Full Text] [Related]
17. Anti-oxidative stress effect of red ginseng in the brain is mediated by peptidyl arginine deiminase type IV (PADI4) repression via estrogen receptor (ER) β up-regulation.
Kim EH; Kim IH; Lee MJ; Thach Nguyen C; Ha JA; Lee SC; Choi S; Choi KT; Pyo S; Rhee DK
J Ethnopharmacol; 2013 Jul; 148(2):474-85. PubMed ID: 23665163
[TBL] [Abstract][Full Text] [Related]
18. Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies,
Guderud K; Mæhlen MT; Nordang GBN; Viken MK; Andreassen BK; Molberg Ø; Flåm ST; Lie BA
J Rheumatol; 2018 Aug; 45(9):1211-1219. PubMed ID: 29858238
[TBL] [Abstract][Full Text] [Related]
19. Expression of peptidylarginine deiminase type 4 in ovarian tumors.
Wang L; Chang X; Yuan G; Zhao Y; Wang P
Int J Biol Sci; 2010 Aug; 6(5):454-64. PubMed ID: 20827398
[TBL] [Abstract][Full Text] [Related]
20. Role of peptidylarginine deiminase type 4 in gastric cancer.
Xin J; Song X
Exp Ther Med; 2016 Nov; 12(5):3155-3160. PubMed ID: 27882131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
